← All trials
NCT00528190
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2007
- Primary completion
- Aug 1, 2010
- Completion date
- May 1, 2011
- First posted
- —
- Last posted
- —
- Enrollment
- 35
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- University of OttawaLead sponsor
- University of OttawaOverall official - principal investigator
- University of TorontoCollaborator
- Canadian Cystic Fibrosis FoundationCollaborator
- The Physicians' Services Incorporated FoundationCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.